Applying Tumor Treating Fields (TTFields) Via Electrodes Embedded into Skull Implants
Tumors inside a person's head (e.g., brain tumors) can be treated using tumor treating fields (TTFields) by positioning capacitively coupled electrodes on opposite sides of the tumor, and applying an AC voltage between the electrodes. Unlike the conventional approach (in which all of the electrodes are positioned on the person's scalp) at least one of the electrodes is implemented using an implanted apparatus. The implanted apparatus includes a rigid substrate shaped and dimensioned to replace a section of the person's skull. At least one electrically conductive plate is affixed to the inner side of the rigid substrate, and a dielectric layer is disposed on the inner side of the conductive plate or plates. An electrically conductive lead is used to apply an AC voltage to the conductive plate or plates.
Latest Novocure GmbH Patents:
- Amplitude modulation for tumor treating fields
- SHIFTABLE TRANSDUCER ARRAY WITH ANISOTROPIC MATERIAL LAYER
- Enhanced-flexibility transducer arrays for delivering TTFields (tumor treating fields)
- Enhanced-flexibility transducer arrays for delivering TTFields (tumor treating fields)
- COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS
This Application is a divisional of U.S. Ser. No. 16/937,695, filed Jul. 24, 2020, which claims the benefit of U.S. Provisional Application 62/880,893, filed Jul. 31, 2019, each of which is incorporated herein by reference in its entirety.
BACKGROUNDTumor Treating Fields, or TTFields, are low intensity (e.g., 1-3 V/cm) alternating electric fields within the intermediate frequency range (e.g., 100-500 kHz) that inhibit cancer cell growth. This non-invasive treatment targets solid tumors and is described in U.S. Pat. No. 7,565,205, which is incorporated herein by reference in its entirety. 200 kHz TTFields are FDA approved for the treatment of glioblastoma (GBM), and may be delivered, for example, via the Optune™ system. Optune™ includes a field generator and two pairs of transducer arrays (i.e., electrode arrays) that are placed on the patient's shaved head. One pair of arrays is positioned to the left and right of the tumor, and the other pair of arrays is positioned anterior and posterior to the tumor.
SUMMARY OF THE INVENTIONOne aspect of the invention is directed to a first apparatus. The first apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull. The substrate has an inner side and an outer side. The first apparatus also comprises an electrically conductive plate having an inner side and an outer side. The outer side of the plate is affixed to the inner side of the substrate. The first apparatus also comprises a dielectric layer disposed on the inner side of the plate; and an electrically conductive lead having an inner end and an outer end. The inner end of the lead is disposed in electrical contact with the plate, the lead passes through the substrate, and the outer end of the lead is configured to accept an electrical signal from an external device.
Some embodiments of the first apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer. Optionally, these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device. Optionally, in these embodiments, the temperature sensor comprises a thermistor.
In some embodiments of the first apparatus, the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the first apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
Another aspect of the invention is directed to a second apparatus. The second apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull. The substrate has an inner side and an outer side. The second apparatus also comprises a plurality of electrically conductive plates, each having an inner side and an outer side. The outer side of each plate is affixed to the inner side of the substrate. The second apparatus also comprises a dielectric layer disposed on the inner side of each plate; and a first electrically conductive lead having an inner end and an outer end. The inner end of the first lead is disposed in electrical contact with a first one of the plates, the first lead passes through the substrate, and the outer end of the first lead is configured to accept an electrical signal from an external device.
Some embodiments of the second apparatus further comprise a second electrically conductive lead having an inner end and an outer end. The inner end of the second lead is disposed in electrical contact with a second one of the plates, the second lead passes through the substrate, and the outer end of the second lead is configured to accept an electrical signal from the external device.
Some embodiments of the second apparatus further comprise an additional electrically conductive lead disposed to electrically connect the first one of the plates with a second one of the plates.
Some embodiments of the second apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer. Optionally, these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device. Optionally, in these embodiments, the temperature sensor comprises a thermistor.
In some embodiments of the second apparatus, the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the second apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
Another aspect of the invention is directed to a first method of treating a tumor in a person's head. The first method comprises positioning a first set of electrodes on an inner side of a first skull implant on a first side of the tumor; positioning a second set of electrodes on a second side of the tumor that is opposite to the first side; and applying an AC voltage between the first set of electrodes and the second set of electrodes to generate an alternating electric field that passes through the tumor.
In some instances of the first method, the second set of electrodes is positioned on an inner side of the first skull implant. In some instances of the first method, the second set of electrodes is positioned on an inner side of a second skull implant. In some instances of the first method, the second set of electrodes is positioned on an exterior surface of the person's head.
Various embodiments are described in detail below with reference to the accompanying drawings, wherein like reference numerals represent like elements.
DESCRIPTION OF THE PREFERRED EMBODIMENTSIn a patient with glioblastoma, when the Optune™ transducer arrays are positioned on a patient's shaved head, the electric field must pass through the patient's scalp and skull twice in order to reach the tumor. This situation introduces two problems. First, the presence of the skull between the transducer array and the tumor makes it more difficult to aim the field at the desired location (i.e., the tumor bed) in the brain. And second, due to attenuation of the electric field introduced by the skull and scalp, the voltage and current that is applied to the transducer arrays must be relatively high (e.g., on the order of 50 VAC and on the order of 1 A) in order to obtain an electric field with a therapeutically effective magnitude in the tumor bed.
An electrically conductive plate 22 is affixed to the inner side of the substrate 20. This plate 22 is preferably metal (e.g., copper, steel, etc.), but alternative conductive materials may also be used. The shape of the plate 22 may be customized to match the contours of the substrate 20, and the outer side of the plate 22 may be affixed to the substrate 20 using any of a variety of conventional approaches including but not limited to 3D printing and adhesives. A dielectric layer 24 is disposed on the inner side of the plate 22.
In many situations, it is preferable to capacitively coupled the electric field into the target region. The conductive plate 22 and the dielectric layer 24 form a capacitor, and using a higher capacitance improves the coupling of the electric field into the tumor. One approach for achieving a high capacitance is to use a ceramic dielectric material with a dielectric constant of at least 10,000 for implementing the dielectric layer 24, similar to the approach used in the conventional Optune™ system. An alternative approach for increasing the capacitance is to use a flexible thin layer of high dielectric polymer as the dielectric layer 24.
Any portion of the conductive plate 22 that is not covered by the dielectric 24 should be covered by an appropriate insulator (e.g., medical grade silicone) to prevent non-capacitive coupling between the conductive plate 22 and tissue in the patient's head.
The inner end of an electrically conductive lead 26 (e.g., a wire) is disposed in electrical contact with the plate 22. The lead 26 passes through the substrate 20, and the outer end of the lead 26 is configured to accept an electrical signal from an external device (e.g., the field generator 11 depicted in
Assume, for example, that four sets of the apparatus 10 depicted in
Preferably, at least one temperature sensor (e.g. a thermistor, not shown) is integrated into each implant 10 A/P/L/R to reduce the risk of overheating any portion of the patient's brain. In some embodiments, appropriate wiring (not shown) passes through the substrate 20 and is used to route the signal from the temperature sensor to the system's controller (which may be located, for example, in the field generator 11 shown in
In the
Notably, since the electric field does not have to pass through the scalp or skull, the voltage and current used in this embodiment can be significantly lower than the voltage and current used in the conventional Optune™ system for any given desired field strength at the tumor. (This is because in the conventional Optune™ system, the electrodes are all positioned on the shaved scalp of the patient, which means that the electric field must traverse the scalp and skull twice to reach the tumor.)
In addition, when the transducer arrays are incorporated into skull implants, the planning of treatment so that the desired field appears in the tumor bed may be simplified because the electrical path between the transducer arrays on opposite sides of the tumor is simplified. Finally, incorporating transducer arrays into skull implants can improve treatment planning in situations where the position of a surgical wound or skin abnormalities might prevent the application of conventional Optune™ transducer arrays to particular places on the surface of a patient's skin.
Note that
In other alternative embodiments, two or more sets of electrodes are incorporated into a single skull implant. For example, a single roughly hemispherical skull implant could be installed on a patient's head in place of the top hemisphere of the patient's skull, and all four sets of electrodes could be incorporated into that single skull implant (i.e., on the left, right, anterior, and posterior inner walls of the implant).
While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims, and equivalents thereof.
Claims
1. A method of treating a tumor in a person's head, the method comprising:
- positioning a first set of electrodes on an inner side of a first skull implant on a first side of the tumor;
- positioning a second set of electrodes on a second side of the tumor that is opposite to the first side; and
- applying an AC voltage between the first set of electrodes and the second set of electrodes to generate an alternating electric field that passes through the tumor.
2. The method of claim 1, wherein the second set of electrodes is positioned on an inner side of the first skull implant.
3. The method of claim 1, wherein the second set of electrodes is positioned on an inner side of a second skull implant.
4. The method of claim 1, wherein the second set of electrodes is positioned on an exterior surface of the person's head.
Type: Application
Filed: Apr 13, 2023
Publication Date: Aug 10, 2023
Applicant: Novocure GmbH (Root)
Inventors: Yoram WASSERMAN (Haifa), Uri WEINBERG (Binyamina), Zeev BOMZON (Kiryat Tivon)
Application Number: 18/134,351